The Babe's Trades

[riverbabe]

Was it fear or greed that got to you????

just greed honey...

[Deaddog]

Bot back in AMRN 10.45. We'll see what Monday brings.

Was it fear or greed that got to you????

[riverbabe]

Bot back in AMRN 10.45. We'll see what Monday brings.

[Deaddog]

sold AMRN 10.68, +22.8% one day gain

Yea Babe!!!!

[riverbabe]

sold AMRN 10.68, +22.8% one day gain

[riverbabe]

amrn

Everybody jumping on the bandwagon again. Up 16+% since I bot yesterday. Have sell day-order in at today's high 10.68. I'll get back in lower later. Shoot, it's just taking a one-day $3,000 profit and running.

Here's the scoop: Friday, March 16, 11:08 AM Shares of Amarin (AMRN +12.2%) soar after the USPTO updates its transaction history for one of the company's patents to read in a more positive light. At least part of the rise in Amarin's share price can also be attributed to ongoing M&A chatter kicked off earlier this week. Comment! [Healthcare, On the Move]
Thursday, March 15, 12:26 PM Sparking gains in Irish biotech firm Amarin (AMRN +8.6%) is a Leerink Swann note speculating that "patent progress could solidify Amarin as a prime takeout candidate given the blockbuster potential for [heart-drug candidate] AMR-101." The firm had earlier said AMRN was moving toward winning its quest for U.S. patent protection for AMR-101. Comment! [Healthcare, M&A, On the Move]
Friday, March 9, 11:01 AM While the good news for investors of Amarin (AMRN +1.1%) is that development on its experimental heart drug derived from fish oil is churning right along, the bad news is that the USPTO can't keep up with the pace to help the company keep generic versions at bay. Leerink Swann predicts the patent office will eventually grant approval after a lengthy appeals process, as it maintains an Outperformance rating and $25 price target on the biotech firm. 1 Comment [On the Move, Healthcare]

[riverbabe]

Current holdings: (mental 7% stops only)
AGNC 29.36, tgt 31.17
AMRN 8.69, tgt 25
NUAN 26.13, tgt 31

[riverbabe]

Bot AMRN again. 8.69 av. Patent news coming next day or so. Run-up to FDA decision. Takeover talk again. We'll see. http://seekingalpha.com/article/3781...ucky-investors

Amarin (AMRN) - Drug: AMR101 for dyslipidemia - Decision Date: July 26, 2012

[riverbabe]

Sld TDC this AM. Looking toppy. Bot @ 56.22, sold 63.85, +13.57%

LONG:

AGNC -- bot 29.36, 2/22 close 30.57, +4.46% (holding for divi till tax time)

SHORT:

DMND -- sell 22.90, 2/22 close 23.95, buy to cover order @23.95 keeps flirting with 8% stop. time to say goodbye.

Unbelievable! I usually have about 10 stocks in the works at any given time. But cash is good for right now. Looking for opportunity!

[riverbabe]

Sld NVDA at close before earnings yesterday. Bot @ 15.00, sold 16.21. +8.07%

LONG:

TDC -- bot 56.22, 2/15 close 61.75, +9.83%
AGNC -- bot 29.36, 2/15 close 30.71, +4.60% (holding for divi till tax time)

SHORT:

DMND -- sell 22.90, 2/15 close 23.46, -2.45%
(not happy with the action in this one. looking to dump soon.)

[riverbabe]

LONG:

NVDA -- bot 15.00, 2/13 close 16.15, +7.63% (earnings tomorrow)
TDC -- bot 56.22, 2/13 close 61.62, +9.60%
AGNC -- bot 29.36, 2/13 close 30.42, +3.61% (holding for divi till tax time)

SHORT:

DMND -- sell 22.90, 2/13 close 22.10, (wait for it!!!) +3.47%

[riverbabe]

LONG:

NVDA -- bot 15.00, 2/10 close 15.90, +5.93%
TDC -- bot 56.22, 2/10 close 62.06, +10.38
AGNC -- bot 29.36, 2/10 close 30.20, +2.84% (holding for divi till tax time)

SHORT:

DMND -- sell 22.90, 2/10 close 23.52, -2.71%

[riverbabe]

Be nice to know if it's the smartmoney getting in or out.

Short covering?????

I was hoping it was short profit taking, but why if it's going down further? You may be deaddog right about someone likes it here and sellers limiting losses? 4X vol and it's not 1:30 yet?

[Deaddog]

There is a lot of scary big lot trading going on both sides of Level II.

Be nice to know if it's the smartmoney getting in or out.

Short covering?????

[mrmarket]

Wow...you're own thread! This ought to drive up the website hits!!